Table of Contents

company-logo

CrystalGenomics, Inc., a biopharmaceutical company, discovers and develops structural chemoproteiomics-based drugs in Korea. Its lead development candidate is NSAID (CG100649), which is a tissue specific anti-inflammatory agent with cardiovascular, gastrointestinal, and renal safety profiles that has completed Phase IIa clinical trial. The company's drug candidates also include CG200745, a histone deacetylase inhibitor for cancer, which is in Phase I clinical trial; and CG400549, an antibiotic candidate for methicillin resistant staphylococcus aureus and vancomycin resistant staphylococcus aureus, which is in Phase I clinical trial. In addition, it offers cloning, expression, purification, and characterization of proteins of interest; and assay and structure services. The company has drug discovery collaborations with AstraZeneca, Daiichi-Sankyo, SBI-Biotech, Carna Biosciences, Yuyu Pharma, AmorePacific, Hanmi Pharmaceuticals, and ProQuest Investments. CrystalGenomics, Inc. was founded in 2000 and is headquartered in Seongnam, South Korea.

CrystalGenomics Dividend Announcement

• CrystalGenomics announced a annually dividend of ₩0.28 per ordinary share which will be made payable on . Ex dividend date: 2022-03-15
• CrystalGenomics's trailing twelve-month (TTM) dividend yield is -%

CrystalGenomics Dividend History

Ex-Div dateDividend amountDividend typePay date
2022-03-15₩0.28annually

CrystalGenomics Dividend per year

CrystalGenomics Dividend Yield

CrystalGenomics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing CrystalGenomics stock? Use our calculator to estimate your expected dividend yield:

CrystalGenomics Financial Ratios

P/E ratio-2.99
PEG ratio-0.03
P/B ratio1.54
ROE-45.92%
Payout ratio0.00%
Current ratio0.78
Quick ratio0.78
Cash Ratio0.00

CrystalGenomics Dividend FAQ

Does CrystalGenomics stock pay dividends?
CrystalGenomics does not currently pay dividends to its shareholders.
Has CrystalGenomics ever paid a dividend?
No, CrystalGenomics has no a history of paying dividends to its shareholders. CrystalGenomics is not known for its dividend payments.
Why doesn't CrystalGenomics pay dividends?
There are several potential reasons why CrystalGenomics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will CrystalGenomics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While CrystalGenomics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is CrystalGenomics a dividend aristocrat?
CrystalGenomics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is CrystalGenomics a dividend king?
CrystalGenomics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is CrystalGenomics a dividend stock?
No, CrystalGenomics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy CrystalGenomics stocks?
To buy CrystalGenomics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy CrystalGenomics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.